Pfizer-BioNTech COVID-19 vaccine outperforms Sinovac jab in antibody study

The mRNA vaccine developed by Pfizer and BioNTech generates far higher levels of antibodies against the coronavirus than Sinovac’s inactivated virus prophylactic, according to a study.